Myer Vickesh 4
4 · Editas Medicine, Inc. · Filed Feb 8, 2019
Insider Transaction Report
Form 4
Myer Vickesh
Chief Technology Officer
Transactions
- Award
Stock Option (right to buy)
2019-02-06+48,750→ 48,750 totalExercise: $21.10Exp: 2029-02-05→ Common Stock (48,750 underlying) - Award
Restricted Stock Units
2019-02-06+8,125→ 8,125 total→ Common Stock (8,125 underlying)
Footnotes (3)
- [F1]This option was granted on February 6, 2019 and is scheduled to vest over four years in equal monthly installments beginning on February 6, 2019 through February 6, 2023.
- [F2]Each restricted stock unit represents the right to receive one share of common stock of Editas Medicine, Inc.
- [F3]The restricted stock unit award is scheduled to vest over four years with 25% of the units vesting on February 6, 2020 and the remaining 75% of the units scheduled to vest in equal quarterly installments thereafter through February 6, 2023. Shares will be delivered to the Reporting Person when units vest.